000 01542 a2200409 4500
005 20250514185442.0
264 0 _c20040604
008 200406s 0 0 eng d
022 _a0002-9378
024 7 _a10.1016/j.ajog.2004.02.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerchuck, Andrew
245 0 0 _aPrediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays.
_h[electronic resource]
260 _bAmerican journal of obstetrics and gynecology
_cApr 2004
300 _a910-25 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCystadenocarcinoma, Serous
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aNeoplasm, Residual
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aOvariectomy
_xmethods
650 0 4 _aPredictive Value of Tests
650 0 4 _aRNA, Neoplasm
_xanalysis
700 1 _aIversen, Edwin S
700 1 _aLancaster, Johnathan M
700 1 _aDressman, Holly K
700 1 _aWest, Mike
700 1 _aNevins, Joseph R
700 1 _aMarks, Jeffrey R
773 0 _tAmerican journal of obstetrics and gynecology
_gvol. 190
_gno. 4
_gp. 910-25
856 4 0 _uhttps://doi.org/10.1016/j.ajog.2004.02.005
_zAvailable from publisher's website
999 _c14829099
_d14829099